View All Attorneys


John S. Rudd

John S. Rudd
  • 919.829.4289
  • Download vCard
  • Connect
  • Printable Profile

John S. Rudd

John advises life sciences and technology companies in all stages of a company’s life cycle. John typically acts as outside general counsel working closely with founders, management teams and boards of directors on company startups and formations, licensing of intellectual property, venture capital financings, commercial transactions, mergers and acquisitions and other strategic transactions. Prior to joining Hutchison, John was an associate in the mergers and acquisitions group of Jones Day’s Tokyo office, where he advised public companies and private equity clients on various types of cross-border transactions, including acquisitions, divestitures, licenses and strategic partnerships.

Recognition, Affiliations & Memberships

  • Board of Directors, Applied Synergies Partnership


  • LL.M., International and Comparative Law, Duke University Law School, 2012
  • J.D., magna cum laude, Duke University Law School, 2012
  • B.A., with honors and highest distinction, University of North Carolina at Chapel Hill, 2008  


  • New York
  • North Carolina


  • Japanese

Fred and John are highly responsive and knowledgeable. We are always impressed with the quick responses and thoughtful advice. We trust their advice and appreciate their partnership approach.

Susan Nichols CEO, Falcon Therapeutics

John was fantastic at breaking down the important sections of the contracts to help determine the most important matters to negotiate. The volume of documents and the length of them would have been overwhelming without him navigating me through them!

Penny Shikowitz CEO, On Track Technologies

Bill and John were both really responsive. There were a lot of parties involved which complicated the transaction, but Bill and John did a great job navigating all the dialogues and getting the financing to a close in an industry precedence setting time.

Shawn Leland Founder and Chief Business Officer, Elevation Oncology

John Rudd was very detail oriented and helped us navigate a complex closing with many investor groups. He did a great job.

Christopher Belnap CEO, Resilient Biotics, Inc.

Recent Blog Posts